PMID: 3933144Oct 1, 1985Paper

Effect of thyroid hormones on liver microsomal enzyme induction in rats exposed to 2,3,7,8,-tetrachlorodibenzo-p-dioxin

Karl K RozmanA Parkinson


The effect of thyroidectomy and thyroid hormone replacement therapy on liver microsomal enzyme induction was studied in 2,3,7,8,-tetrachlorodibenzo-p-dioxin (TCDD)-treated rats (100 micrograms/kg). Treatment of non-thyroidectomized rats with TCDD had no effect on the concentration of liver microsomal cytochrome b5. In contrast, cytochrome b5 content was increased by TCDD treatment of thyroidectomized rats, regardless of replacement therapy with either T3 or T4. TCDD treatment increased the concentration of cytochrome P-450 (2-3-fold) and the activities of benzo[a]pyrene hydroxylase (4-7-fold), ethoxyresorufin O-de-ethylase (50-70-fold) and UDP-glucuronosyltransferase (5-7-fold) in non-thyroidectomized and thyroidectomized as well as thyroidectomized thyroid hormone treated rats; indicating the induction of these liver microsomal enzyme activities is independent of thyroid status. Because thyroid status alters the toxicity of TCDD but does not alter the ability of TCDD to induce microsomal enzymes, it appears that TCDD toxicity may not be directly related to microsomal enzyme induction.


Jan 12, 1976·Biochemical and Biophysical Research Communications·P Beatty, R A Neal
May 31, 1979·Annals of the New York Academy of Sciences·R A NealT A Gasiewicz
May 31, 1979·Annals of the New York Academy of Sciences·R J KocibaP J Gehring
Jan 1, 1977·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·R Kato
Jan 1, 1978·Toxicology and Applied Pharmacology·E E McConnellD W Dalgard
Nov 1, 1976·Bulletin of Environmental Contamination and Toxicology·P W BeattyR A Neal
May 1, 1976·Toxicology and Applied Pharmacology·J Q RoseP J Gehring
Jan 1, 1985·Journal of Toxicology and Environmental Health·K RozmanH Greim
Sep 1, 1973·Environmental Health Perspectives·J B Greig, F De Matteis
Jun 15, 1983·Toxicology and Applied Pharmacology·C L PotterD H Russell
Nov 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·L M Hjelmeland
Jan 1, 1982·Drug Metabolism Reviews·R A NealL E Geiger
Apr 15, 1982·Experientia·H PoigerC Schlatter
May 13, 1982·Brain Research·A Ruiz-MarcosG Morreale de Escobar
Jun 30, 1981·Toxicology and Applied Pharmacology·J M HenckK S Rao
Aug 1, 1980·European Journal of Biochemistry·F L HochL Ernster

❮ Previous
Next ❯


Jan 1, 1987·Archives of Environmental Contamination and Toxicology·R J AulerichA C Napolitano
Jun 15, 1986·Toxicology and Applied Pharmacology·C L PotterR E Peterson
Jan 1, 1986·Toxicology Letters·K RozmanA Parkinson
Jun 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·P BullockA Parkinson
Feb 21, 2006·Biochemical Pharmacology·Patricia A HarperAllan B Okey
Jan 15, 1987·Biochemical Pharmacology·C K KellingR E Peterson
Nov 1, 2014·Expert Review of Endocrinology & Metabolism·Kingsley Ibhazehiebo, Noriyuki Koibuchi
Nov 20, 2018·EFSA Journal·UNKNOWN EFSA Panel on Contaminants in the Food Chain (CONTAM)Laurentius Ron Hoogenboom

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Hereditary Sensory Autonomic Neuropathy

Hereditary Sensory Autonomic Neuropathies are a group of inherited neurodegenerative disorders characterized clinically by loss of sensation and autonomic dysfunction. Here is the latest research on these neuropathies.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Landau-Kleffner Syndrome

Landau Kleffner syndrome (LKS), also called infantile acquired aphasia, acquired epileptic aphasia, or aphasia with convulsive disorder, is a rare childhood neurological syndrome characterized by the sudden or gradual development of aphasia (the inability to understand or express language) and an abnormal electroencephalogram. Discover the latest research on LKS here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.